• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定无肝脏疾病青年人群的受控衰减参数和肝脏硬度值。

Defining values for controlled attenuation parameter and liver stiffness in youth without liver disease.

作者信息

Ramírez-Vélez Robinson, García-Hermoso Antonio, Correa-Rodríguez María, Izquierdo Mikel

机构信息

Department of Health Sciences, Public University of Navarra, Navarrabiomed-IdiSNA, Complejo Hospitalario de Navarra (CHN), Pamplona, Spain.

CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.

出版信息

Pediatr Res. 2022 Mar;91(4):912-920. doi: 10.1038/s41390-021-01441-6. Epub 2021 Apr 12.

DOI:10.1038/s41390-021-01441-6
PMID:33846557
Abstract

BACKGROUND

We aimed to determine the reference values to define an age-specific normal range of controlled attenuation parameter (CAP, a measure of liver steatosis) and liver stiffness measurement (LSM) values assessed by ultrasound-based transient elastography in adolescents without underlying liver disease.

METHODS

A total of 462 participants were included in this cross-sectional study using data from NHANES 2017-2018. LSM and CAP were carried out using the FibroScan® M-probe. Anthropometric, metabolic and hematological parameters were measured.

RESULTS

The median CAP was 199.0 dB/m (150.0-245.0 dB/m, 10th to 90th percentiles) and the median LSM was 4.7 kPa (3.4-6.3 kPa, 10th to 90th percentiles) for ages 12-19.9 years. Regression analyses show that the CAP and LSM were not positively correlated with age (boys CAP R = 0.001, p = 0.576 and LSM R = 0.012, p = 0.096; girls CAP R = 0.011, p = 0.113 and LSM R = 0.006, p = 0.236). Finally, CAP was positively associated with LSM in girls (β = 0.189, p = 0.005) but not in boys (β = -0.083, p = 0.202).

CONCLUSIONS

The reference values indicated here for LSM and CAP will help in the screening of adolescents between ages 12 and 19.9 years and might serve as a useful method for identifying those youth at high risk of nonalcoholic fatty liver disease.

IMPACT

The reference values indicated in this study for liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) will help in the screening of adolescents between ages 12 and 19.9 years in clinical practice. The cutoffs of LSM and CAP might serve as a useful method for identifying those youth at high risk of nonalcoholic fatty liver disease.

摘要

背景

我们旨在确定参考值,以定义无潜在肝脏疾病的青少年通过基于超声的瞬时弹性成像评估的控制衰减参数(CAP,肝脏脂肪变性的一种测量指标)和肝脏硬度测量(LSM)值的特定年龄正常范围。

方法

本横断面研究使用2017 - 2018年美国国家健康与营养检查调查(NHANES)的数据,共纳入462名参与者。使用FibroScan® M探头进行LSM和CAP检测。测量人体测量学、代谢和血液学参数。

结果

12至19.9岁人群的CAP中位数为199.0 dB/m(第10至90百分位数为150.0 - 245.0 dB/m),LSM中位数为4.7 kPa(第10至90百分位数为3.4 - 6.3 kPa)。回归分析表明,CAP和LSM与年龄无正相关(男孩CAP:R = 0.001,p = 0.576;LSM:R = 0.012,p = 0.096;女孩CAP:R = 0.011,p = 0.113;LSM:R = 0.006,p = 0.236)。最后,CAP在女孩中与LSM呈正相关(β = 0.189,p = 0.005),但在男孩中无相关性(β = -0.083,p = 0.202)。

结论

此处给出的LSM和CAP参考值将有助于筛查12至19.9岁的青少年,可能作为识别非酒精性脂肪性肝病高风险青年的有用方法。

影响

本研究中给出的肝脏硬度测量(LSM)和控制衰减参数(CAP)参考值将有助于临床实践中筛查12至19.9岁的青少年。LSM和CAP的临界值可能作为识别非酒精性脂肪性肝病高风险青年的有用方法。

相似文献

1
Defining values for controlled attenuation parameter and liver stiffness in youth without liver disease.确定无肝脏疾病青年人群的受控衰减参数和肝脏硬度值。
Pediatr Res. 2022 Mar;91(4):912-920. doi: 10.1038/s41390-021-01441-6. Epub 2021 Apr 12.
2
Reference values and associated factors of controlled attenuation parameter and liver stiffness in adults: A cross-sectional study.成人受控衰减参数和肝硬度的参考值及其相关因素:一项横断面研究。
Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1879-1889. doi: 10.1016/j.numecd.2024.04.004. Epub 2024 May 15.
3
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
4
Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years.5 岁健康学龄前儿童 FibroScan 502 与 M 探头的可行性研究及参考值。
BMC Pediatr. 2019 Apr 24;19(1):129. doi: 10.1186/s12887-019-1487-6.
5
Potential impact of screening for fatty liver disease by transient elastography with liver stiffness and controlled attenuation parameter measurements: a pilot study.通过瞬时弹性成像测量肝脏硬度和控制衰减参数筛查脂肪肝疾病的潜在影响:一项试点研究。
Z Gastroenterol. 2017 Aug;55(8):754-760. doi: 10.1055/s-0043-111804. Epub 2017 Jun 27.
6
Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.在经肝活检证实患有非酒精性脂肪性肝病的日本患者中,联合使用肝脏硬度测量值和受控衰减参数预测肝脏相关事件。
Ultrasound Med Biol. 2023 Jul;49(7):1658-1664. doi: 10.1016/j.ultrasmedbio.2023.03.023. Epub 2023 Apr 27.
7
Pediatric percentiles for transient elastography measurements - effects of age, sex, weight status and pubertal stage.儿童瞬时弹性成像测量的百分位数 - 年龄、性别、体重状况和青春期阶段的影响。
Front Endocrinol (Lausanne). 2022 Sep 27;13:1030809. doi: 10.3389/fendo.2022.1030809. eCollection 2022.
8
Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study.使用 FibroScan M/XL 探头测量肝脏硬度和受控衰减参数诊断非酒精性脂肪性肝病患者肝纤维化和脂肪变性的准确性:一项多中心前瞻性研究。
J Gastroenterol. 2020 Apr;55(4):428-440. doi: 10.1007/s00535-019-01635-0. Epub 2019 Oct 25.
9
Applicability and Results of Liver Stiffness Measurement and Controlled Attenuation Parameter Using XL Probe for Metabolic-Associated Fatty Liver Disease in Candidates to Bariatric Surgery. A Single-Center Observational Study.使用 XL 探头测量肝硬度和控制衰减参数在代谢相关脂肪性肝病患者中的适用性和结果,用于减重手术候选者。一项单中心观察性研究。
Obes Surg. 2021 Feb;31(2):702-711. doi: 10.1007/s11695-020-04971-w. Epub 2020 Sep 22.
10
Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.瞬时弹性成像技术评估的肝纤维化和脂肪变对非酒精性脂肪性肝病合并 2 型糖尿病患者心血管和死亡结局的预后影响:里约热内卢队列研究。
Cardiovasc Diabetol. 2021 Sep 24;20(1):193. doi: 10.1186/s12933-021-01388-2.

引用本文的文献

1
Diagnostic indicators and lifestyle interventions of metabolic-associated fatty liver disease.代谢相关脂肪性肝病的诊断指标及生活方式干预
Front Nutr. 2024 Jun 14;11:1424246. doi: 10.3389/fnut.2024.1424246. eCollection 2024.
2
Clinical research of fibroscan ‒ TE-CAP at noninvasive diagnosis of hepatic steatosis in children.纤维弹性成像技术 - TE-CAP 无创诊断儿童肝脂肪变的临床研究。
Clinics (Sao Paulo). 2024 May 27;79:100387. doi: 10.1016/j.clinsp.2024.100387. eCollection 2024.
3
Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors.
年轻人非酒精性脂肪性肝病的决定因素:母体、新生儿和青少年因素。
PLoS One. 2024 Feb 22;19(2):e0298800. doi: 10.1371/journal.pone.0298800. eCollection 2024.
4
Inverted U-shaped relationships between bone mineral density and VCTE-quantified degree of hepatic steatosis in adolescents: Evidence from the NHANES.青少年骨密度与 VCTE 定量肝脂肪变性程度之间的倒 U 型关系:来自 NHANES 的证据。
PLoS One. 2023 Jun 9;18(6):e0286688. doi: 10.1371/journal.pone.0286688. eCollection 2023.
5
Association between hypertension and the prevalence of liver steatosis and fibrosis.高血压与肝脂肪变性和纤维化患病率的关系。
BMC Endocr Disord. 2023 Apr 20;23(1):85. doi: 10.1186/s12902-023-01318-1.
6
Pediatric percentiles for transient elastography measurements - effects of age, sex, weight status and pubertal stage.儿童瞬时弹性成像测量的百分位数 - 年龄、性别、体重状况和青春期阶段的影响。
Front Endocrinol (Lausanne). 2022 Sep 27;13:1030809. doi: 10.3389/fendo.2022.1030809. eCollection 2022.
7
Association between type 2 diabetes status and prevalence of liver steatosis and fibrosis among adults aged ≥ 40 years.2 型糖尿病与≥40 岁成年人肝脂肪变性和纤维化患病率之间的关联。
BMC Endocr Disord. 2022 May 13;22(1):128. doi: 10.1186/s12902-022-01046-y.